# Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy

> **NCT06181682** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 70 (estimated)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06181682
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06181682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06181682, "Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06181682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*